Morphine Sulfate Market Size, Share Global Analysis Report, 2022 – 2028

Industry Insights

[235+ Pages Report] According to Facts and Factors, the global morphine sulfate market size was valued at USD 2.3 billion in 2021 and is predicted to increase at a CAGR of 7.9% to USD 6.5 billion by 2028. The study examines the market in terms of revenue in each of the major regions, which are classified into countries.

Market Overview

Morphine sulfate is used to treat severe pain and is used to provide relief to patients that are suffering from extreme pain in disease or other disorders. Morphine reduces pain by binding to opioid receptors in the central nervous system and hence reduces the sensation of pain to a bearable extent. It is used in multiple medical applications to reduce pain and treat disorders in a bearable manner for most patients. Morphine sulfate can be used in long term as well as short term and can be administered via IV drip, tablets, injections, etc.

Increasing healthcare expenditure and rising focus on healthcare are projected to boost demand for Morphine sulfate over the forecast period. The increasing prevalence of chronic diseases is expected to bolster demand for Morphine sulfate in the coming years. However, substance abuse and addiction risks are expected to have a hindering effect on the global Morphine sulfate market potential in the long run.

Impact of COVID - 19

The sudden emergence of the COVID-19 pandemic led to major changes in the global economy and had a negative impact on almost all aspects of the world. The morphine sulfate market also experienced a downfall in its growth trend due to the pandemic of 2020. The use of Morphine sulfate was hampered by shifting trends in the healthcare industry during the pandemic in 2020. The morphine sulfate market is expected to rise at a steady pace in the post-pandemic era owing to an increased focus on healthcare across the world and the rising use of Morphine sulfate in the treatment of multiple chronic pain-related diseases. The rising demand for pain management in chronic diseases will further boost the demand for Morphine sulfate in the coming years.  

The complete research study looks at both the qualitative and quantitative aspects of the morphine sulfate market. Both the demand and supply sides of the market have been investigated. The demand side study examines market income in various regions before comparing it to all of the major countries. The supply side research examines the industry's top rivals, as well as their regional and global presence and strategies. Each major country in North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America is thoroughly investigated.

Segmentation Analysis

The global Morphine sulfate market is segregated based on product types, applications, and regions.

The oral tablets segment is expected to hold a significant market share in the global landscape and the rising use of Morphine sulfate tablets is projected to further bolster growth in this segment over the coming years. Increasing consumption of Morphine sulfate is expected to be driven by increasing chronic pain disorders.  However, the risk of substance abuse by consumption of Morphine sulfate is expected to have a hindering effect on the global Morphine sulfate market growth in the long term.

Report Scope

Regional Landscape

The region of North America accounted is expected to account for a major market share in the global morphine sulfate market landscape and is projected to maintain this stance over the forecast period as well. The rising prevalence of chronic diseases and the presence of developed healthcare infrastructure are anticipated to be major factors driving the morphine sulfate market potential in this region. Increasing consumption of pain management drugs will also drive demand for Morphine sulfate in this region over the forecast period.

Asia Pacific region is expected to see high growth over the forecast period owing to the rising focus on healthcare and the increasing prevalence of chronic diseases. Increasing demand for pain management will further bolster the demand for Morphine sulfate in this region.

List of Key Players in the Global Morphine Sulfate Market:

• Mallinckrodt Pharmaceuticals
• Alcaliber
• Purdue Pharma
• Cepia-Sanofi
• Macfarlan Smith
• SUN PHARMA
• Qinghai Pharmaceutical
• Taj Pharmaceuticals
• Northeast Pharm

The Global Corporate Morphine Sulphate is segmented as follows:

By Product types

• Superior grade
• General grade

By Application

• Oral Tablets
• Injection
• Capsule
• Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Nordic Countries
    • Denmark
    • Sweden
    • Norway
  • Benelux Union
    • Belgium
    • The Netherlands
    • Luxembourg
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Southeast Asia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Rest of Southeast Asia
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America